Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Petroni

Showing results (11-20 of 131) with videos related to

Pageof 14
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 25, 2016
Statistical controversies in clinical research: early-phase adaptive design for combination immunotherapiesN A Wages, C L Slingluff, G R Petroni
Contemporary Clinical Trials|February 2, 2015
A Phase I/II adaptive design to determine the optimal treatment regimen from a set of combination immunotherapies in high-risk melanomaNolan A Wages, Craig L Slingluff, Gina R Petroni
Pharmaceutical Statistics|May 13, 2015
A Phase I/II adaptive design for heterogeneous groups with application to a stereotactic body radiation therapy trialNolan A Wages, Paul W Read, Gina R Petroni
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapyR J Santen, J Pinkerton, C McCartney, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Quality of life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancerT Krupski, G R Petroni, E A Bissonette, et al.
European Urology|April 23, 2003
The impact of prostate volume following neoadjuvant androgen deprivation on quality of life and voiding symptoms in patients undergoing permanent prostate brachytherapyTracey Krupski, Eric A Bissonette, Gina R Petroni, et al.
Urology|May 3, 2000
Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancerT Krupski, G R Petroni, E A Bissonette, et al.
Statistics in Medicine|March 2, 2016
Implementation of adaptive methods in early-phase clinical trialsGina R Petroni, Nolan A Wages, Gautier Paux, et al.
Urology|May 3, 2000
Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostateT Krupski, G R Petroni, H F Frierson, et al.
Cancer|June 8, 2001
Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma: comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapyB R Fulmer, E A Bissonette, G R Petroni, et al.
Pageof 14

Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 25, 2016
Statistical controversies in clinical research: early-phase adaptive design for combination immunotherapiesN A Wages, C L Slingluff, G R Petroni
Contemporary Clinical Trials|February 2, 2015
A Phase I/II adaptive design to determine the optimal treatment regimen from a set of combination immunotherapies in high-risk melanomaNolan A Wages, Craig L Slingluff, Gina R Petroni
Pharmaceutical Statistics|May 13, 2015
A Phase I/II adaptive design for heterogeneous groups with application to a stereotactic body radiation therapy trialNolan A Wages, Paul W Read, Gina R Petroni
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapyR J Santen, J Pinkerton, C McCartney, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Quality of life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancerT Krupski, G R Petroni, E A Bissonette, et al.
European Urology|April 23, 2003
The impact of prostate volume following neoadjuvant androgen deprivation on quality of life and voiding symptoms in patients undergoing permanent prostate brachytherapyTracey Krupski, Eric A Bissonette, Gina R Petroni, et al.
Urology|May 3, 2000
Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancerT Krupski, G R Petroni, E A Bissonette, et al.
Statistics in Medicine|March 2, 2016
Implementation of adaptive methods in early-phase clinical trialsGina R Petroni, Nolan A Wages, Gautier Paux, et al.
Urology|May 3, 2000
Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostateT Krupski, G R Petroni, H F Frierson, et al.
Cancer|June 8, 2001
Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma: comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapyB R Fulmer, E A Bissonette, G R Petroni, et al.
Pageof 14